Pacira BioSciences

Pacira BioSciences

Yahoo Finance • 22 hours ago

Pacira (PCRX) Up 6.9% Since Last Earnings Report: Can It Continue?

It has been about a month since the last earnings report for Pacira (PCRX). Shares have added about 6.9% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is... Full story

Yahoo Finance • 28 days ago

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Aug. 07, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of... Full story

Yahoo Finance • 30 days ago

Pacira Swings To Profit In Q2, Revises FY26 Guidance Following Iovera Divestiture

(RTTNews) - Pacira BioSciences, Inc. (PCRX) recorded a profit in the second quarter ended June 30, 2026, as a result of higher revenue. The company highlighted business and clinical updates along with its updated full-year 2026 guidance.... Full story

Yahoo Finance • last month

Pacira outlines $735M-$760M 2026 revenue guidance while targeting 160M EXPAREL covered lives

Earnings Call Insights: Pacira BioSciences (PCRX) Q2 2026 MANAGEMENT VIEW * "Our second quarter performance reflects disciplined execution of our 5x30 strategy, translating into commercial momentum, strong cash generation, pipeline adv... Full story

Yahoo Finance • last month

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

The Johnson & Johnson, Pacira BioSciences and Orthofix executive takes charge of commercial execution as adoption of Canopus by eXeX accelerates across hospital systems in the United States and United Kingdom, and as eXeX launches Canopus... Full story

Yahoo Finance • 2 months ago

PharmaCorp Closes Previously Announced Eight-Store Acquisition and Provides Acquisition Pipeline Update

Eight pharmacies acquired at an aggregate purchase price of approximately $24.2 millionThe acquisitions increase PharmaCorp’s store count to 14 locations, more than doubling its operating footprint SASKATOON, Saskatchewan, July 06, 2026... Full story

Yahoo Finance • 3 months ago

Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees

Clarifies DOMA’s Inaccuracies and the Reality of Pacira’ Efforts to Strengthen its Market Position Urges Stockholders to Vote “FOR” the Election of Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today BRISBANE, Calif., May 27... Full story

Yahoo Finance • 3 months ago

PharmaCorp Announces Definitive Agreement to Acquire PharmaChoice Canada Bannered Pharmacy in Ontario

Purchase price of approximately $8.2 millionThe acquisition represents a continued expansion of PharmaCorp’s footprint in Ontario SASKATOON, Saskatchewan, May 25, 2026 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corpora... Full story

Yahoo Finance • 3 months ago

Pacira shareholders lobbied by hedge fund board nominees

[Row of empty chairs in board room] Klaus Vedfelt Shareholders of Pacira BioSciences (PCRA) have been told by two individuals backed by DOMA Perpetual Capital Management to join the biopharma's board to ignore criticisms of them by manage... Full story

Yahoo Finance • 4 months ago

Pacira BioSciences Files Investor Presentation Highlighting Successful Execution of its Long-Term Strategy to Drive Value for All Stockholders

Urges Stockholders to Vote “FOR” the Election of Pacira’s Highly Qualified Nominees on the BLUE Proxy Card Today BRISBANE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX) (the “Company” or “Pacira”), the... Full story

Yahoo Finance • 4 months ago

PharmaCorp to Acquire Eight Pharmacies and Provides Acquisition Pipeline Update

The acquisition of eight pharmacies at an aggregate purchase price of approximately $24.2 millionThe acquisitions are expected to increase PharmaCorp’s store count from six to fourteen locations, reflecting the planned integration of the t... Full story

Yahoo Finance • 4 months ago

Here are the major earnings after the close Thursday

Major earnings expected after the bell on Thursday include: * Apple (AAPL [https://seekingalpha.com/symbol/AAPL]) * Amgen (AMGN [https://seekingalpha.com/symbol/AMGN]) * Roku (ROKU [https://seekingalpha.com/symbol/ROKU]) * Twilio... Full story

Yahoo Finance • 4 months ago

PharmaCorp Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Fourth quarter 2025 revenue up 75% compared to the fourth quarter 2024Fourth quarter 2025 gross profit increased 78% compared to the fourth quarter 2025Fourth quarter same-store sales up 6% and same-store prescription sales up 3.8 %, suppl... Full story

Yahoo Finance • 5 months ago

PharmaCorp Rx Inc. To Present At The 2026 Bloom Burton & Co. Healthcare Investor Conference

SASKATOON, Saskatchewan, April 02, 2026 (GLOBE NEWSWIRE) -- PharmaCorp Rx Inc. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a Canadian pharmacy services and consolidation platform, announced today that it will deliver a corporate pre... Full story

Yahoo Finance • 5 months ago

Pacira (PCRX) BioSciences Well-Positioned With Genicular Outcomes Registry Evidence

Pacira BioSciences Inc. (NASDAQ:PCRX) is one of the 7 best small-cap drug manufacturing stocks to buy according to hedge funds. On March 2, Pacira BioSciences Inc. (NASDAQ:PCRX) presented data from its IGOR registry at the American Academ... Full story

Yahoo Finance • 6 months ago

Pacira BioSciences Reaffirms Commitment to Shareholder Value Creation

-- Issues Statement in Response to DOMA’s Nomination of Director Candidates -- -- No Shareholder Action Required at This Time -- BRISBANE, Calif., March 11, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry... Full story

Yahoo Finance • 6 months ago

Sector Update: Health Care Stocks Lower Late Afternoon

Health care stocks were slipping late Wednesday afternoon, with the NYSE Health Care Index down 0.5% PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 8 months ago

PharmaCorp Announces Grant of Stock Options

SASKATOON, Saskatchewan, Dec. 31, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) has granted a total of 501,088 options to purchase common ‎shares to directors, officers, employees and consul... Full story

Yahoo Finance • 8 months ago

DOMA intends to nominate three director candidates at Pacira annual meeting

DOMA Perpetual Capital Management, which beneficially owns approximately 6.83% of the outstanding shares of Common Stock of Pacira (PCRX) BioSciences, announced that it intends to nominate three independent director candidates at the Compa... Full story

Yahoo Finance • 9 months ago

Pharmacorp Rx Inc. Reports Q3 2025 Financial Results

SASKATOON, Saskatchewan, Nov. 28, 2025 (GLOBE NEWSWIRE) -- PHARMACORP RX INC. (“PharmaCorp” or the “Corporation”) (TSXV: PCRX) a growing national platform for pharmacist-led community pharmacy ownership, today reported its financial resu... Full story